Virtus ETF Advisers’s AbbVie ABBV Stock Holding History

Virtus ETF Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$239K	Sell	1,100 -264	-19%	-$58.6K	0.11%	207
2025 Q4	$312K	Buy	1,364 +423	+45%	+$96.4K	0.15%	164
2025 Q3	$218K	Buy	941 +897	+2,039%	+$183K	0.12%	204
2025 Q2	$8.17K	Hold	44	–	–	0.01%	423
2025 Q1	$9.22K	Buy	+44	New	+$8.55K	0.01%	391
2023 Q3	–	Sell	-4,785	Closed	-$645K	–	436
2023 Q2	$645K	Sell	4,785 -1,189	-20%	-$174K	0.38%	121
2023 Q1	$952K	Buy	5,974 +721	+14%	+$110K	0.52%	34
2022 Q4	$849K	Buy	5,253 +655	+14%	+$100K	0.44%	48
2022 Q3	$617K	Sell	4,598 -146	-3%	-$21K	0.25%	163
2022 Q2	$727K	Buy	+4,744	New	+$725K	0.27%	107
2020 Q2	–	Sell	-167	Closed	-$13K	–	443
2020 Q1	$13K	Sell	167 -211	-56%	-$18K	0.01%	364
2019 Q4	$33K	Buy	+378	New	+$31.4K	0.01%	312

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Virtus ETF Advisers's ABBV Position: Q1 2026 in Review

Virtus ETF Advisers reduced its AbbVie (ABBV) stake by 19% in Q1 2026, selling an estimated $58.6K and leaving 1,100 shares worth $239K. The position accounts for 0.11% of the portfolio, ranked #207.

Virtus ETF Advisers first reported a position in ABBV in Q4 2019 and has held it in 12 quarters since. The position peaked at $952K in Q1 2023. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Virtus ETF Advisers held 1,100 shares of AbbVie worth $239K as of Q1 2026.
Virtus ETF Advisers sold 264 AbbVie shares in Q1 2026, an estimated $58.6K.
AbbVie made up 0.11% of Virtus ETF Advisers's portfolio in Q1 2026, its #207 holding.
Virtus ETF Advisers first reported a position in AbbVie in Q4 2019 and has held it in 12 quarters since.
Virtus ETF Advisers's AbbVie position peaked at $952K in Q1 2023.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Virtus ETF Advisers's 13F filing for Q1 2026, filed 14 May 2026.